172 related articles for article (PubMed ID: 22972621)
1. Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis.
de Jong S; Huisman M; Sutedja N; van der Kooi A; de Visser M; Schelhaas J; van der Schouw Y; Veldink J; van den Berg L
J Neurol; 2013 Feb; 260(2):507-12. PubMed ID: 22972621
[TBL] [Abstract][Full Text] [Related]
2. Exposure to endogenous and exogenous sex hormones and reproductive history influence prognosis in women with ALS.
Gonzalez Deniselle MC; Bettini M; Garrido RM; Meyer M; Lara A; Garay LI; Casas S; Fulgenzi E; Nuñez M; Rugiero MF; De Nicola AF; Gargiulo-Monachelli G
Muscle Nerve; 2023 Oct; 68(4):414-421. PubMed ID: 37493444
[TBL] [Abstract][Full Text] [Related]
3. Reproductive History and Age of Onset for Women Diagnosed with Amyotrophic Lateral Sclerosis: Data from the National ALS Registry: 2010-2018.
Raymond J; Mehta P; Larson T; Pioro EP; Horton DK
Neuroepidemiology; 2021; 55(5):416-424. PubMed ID: 34218222
[TBL] [Abstract][Full Text] [Related]
4. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis.
Popat RA; Van Den Eeden SK; Tanner CM; Bernstein AL; Bloch DA; Leimpeter A; McGuire V; Nelson LM
Neuroepidemiology; 2006; 27(3):117-21. PubMed ID: 16946622
[TBL] [Abstract][Full Text] [Related]
5. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.
Osterlind A; Tucker MA; Stone BJ; Jensen OM
Int J Cancer; 1988 Dec; 42(6):821-4. PubMed ID: 3192324
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of hormonal exposures as etiologic factors for ALS in women: Euro-MOTOR.
Rooney JPK; Visser AE; D'Ovidio F; Vermeulen R; Beghi E; Chio A; Veldink JH; Logroscino G; van den Berg LH; Hardiman O;
Neurology; 2017 Sep; 89(12):1283-1290. PubMed ID: 28835399
[TBL] [Abstract][Full Text] [Related]
7. Hormonal and reproductive influences and risk of melanoma in women.
Smith MA; Fine JA; Barnhill RL; Berwick M
Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
[TBL] [Abstract][Full Text] [Related]
8. Prior medical conditions and the risk of amyotrophic lateral sclerosis.
Seelen M; van Doormaal PT; Visser AE; Huisman MH; Roozekrans MH; de Jong SW; van der Kooi AJ; de Visser M; Voermans NC; Veldink JH; van den Berg LH
J Neurol; 2014 Oct; 261(10):1949-56. PubMed ID: 25059395
[TBL] [Abstract][Full Text] [Related]
9. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis.
Byrne S; Heverin M; Elamin M; Bede P; Lynch C; Kenna K; MacLaughlin R; Walsh C; Al Chalabi A; Hardiman O
Ann Neurol; 2013 Nov; 74(5):699-708. PubMed ID: 23836460
[TBL] [Abstract][Full Text] [Related]
10. Exploring the fitness hypothesis in ALS: a population-based case-control study of parental cause of death and lifespan.
Visser AE; Seelen M; Hulsbergen A; de Graaf J; van der Kooi AJ; Raaphorst J; Veldink JH; van den Berg LH
J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):550-556. PubMed ID: 28292782
[TBL] [Abstract][Full Text] [Related]
11. Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis - results from a population- based ALS registry in Germany.
Nagel G; Peter RS; Rosenbohm A; Koenig W; Dupuis L; Rothenbacher D; Ludolph AC
Sci Rep; 2017 Jun; 7(1):4374. PubMed ID: 28663573
[TBL] [Abstract][Full Text] [Related]
12. Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study.
Alonso A; Logroscino G; Jick SS; Hernán MA
BMC Neurol; 2010 Jan; 10():6. PubMed ID: 20074360
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.
Kioumourtzoglou MA; Rotem RS; Seals RM; Gredal O; Hansen J; Weisskopf MG
JAMA Neurol; 2015 Aug; 72(8):905-11. PubMed ID: 26030836
[TBL] [Abstract][Full Text] [Related]
14. Lifetime physical activity and the risk of amyotrophic lateral sclerosis.
Huisman MH; Seelen M; de Jong SW; Dorresteijn KR; van Doormaal PT; van der Kooi AJ; de Visser M; Schelhaas HJ; van den Berg LH; Veldink JH
J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):976-81. PubMed ID: 23418211
[TBL] [Abstract][Full Text] [Related]
15. Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study.
de Jong SW; Huisman MH; Sutedja NA; van der Kooi AJ; de Visser M; Schelhaas HJ; Fischer K; Veldink JH; van den Berg LH
Am J Epidemiol; 2012 Aug; 176(3):233-9. PubMed ID: 22791740
[TBL] [Abstract][Full Text] [Related]
16. Environmental risk factors and amyotrophic lateral sclerosis (ALS): A case-control study of ALS in China.
Lian L; Liu M; Cui L; Guan Y; Liu T; Cui B; Zhang K; Tai H; Shen D
J Clin Neurosci; 2019 Aug; 66():12-18. PubMed ID: 31155341
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival in amyotrophic lateral sclerosis: a population-based study.
Pupillo E; Messina P; Logroscino G; Beghi E;
Ann Neurol; 2014 Feb; 75(2):287-97. PubMed ID: 24382602
[TBL] [Abstract][Full Text] [Related]
18. Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis.
Rosenbohm A; Nagel G; Peter RS; Brehme T; Koenig W; Dupuis L; Rothenbacher D; Ludolph AC;
JAMA Neurol; 2018 May; 75(5):600-607. PubMed ID: 29482216
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study.
Beghi E; Logroscino G; Chiò A; Hardiman O; Millul A; Mitchell D; Swingler R; Traynor BJ
Amyotroph Lateral Scler; 2010 May; 11(3):289-92. PubMed ID: 20433412
[TBL] [Abstract][Full Text] [Related]
20. Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis.
Huisman MH; Seelen M; van Doormaal PT; de Jong SW; de Vries JH; van der Kooi AJ; de Visser M; Schelhaas HJ; van den Berg LH; Veldink JH
JAMA Neurol; 2015 Oct; 72(10):1155-62. PubMed ID: 26280944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
